Literature DB >> 33416047

Speculating on Kleine-Levin Syndrome mechanisms.

Isabelle Arnulf1,2, Elisabeth Groos2, Pauline Dodet2.   

Abstract

Entities:  

Mesh：

Year:  2021        PMID： 33416047      PMCID： PMC7927329          DOI： 10.5664/jcsm.9104

Source DB:  PubMed          Journal:  J Clin Sleep Med        ISSN： 1550-9389            Impact factor:   4.062


× No keyword cloud information.
  5 in total

1.  Emerging psychiatric disorders in Kleine-Levin syndrome.

Authors:  Elisabeth Groos; Charlotte Chaumereuil; Mathilde Flamand; Agnes Brion; Hubert Bourdin; Vanessa Slimani; Michel Lecendreux; Isabelle Arnulf
Journal:  J Sleep Res       Date:  2018-04-14       Impact factor: 3.981

Review 2.  Diagnosis, disease course, and management of patients with Kleine-Levin syndrome.

Authors:  Isabelle Arnulf; Thomas J Rico; Emmanuel Mignot
Journal:  Lancet Neurol       Date:  2012-10       Impact factor: 44.182

3.  Sleep disorders in anti-NMDAR encephalitis.

Authors:  Helena Ariño; Amaia Muñoz-Lopetegi; Eugenia Martinez-Hernandez; Thaís Armangue; Mireia Rosa-Justicia; Domingo Escudero; Nuria Matos; Francesc Graus; Gisela Sugranyes; Josefina Castro-Fornieles; Albert Compte; Josep Dalmau; Joan Santamaria
Journal:  Neurology       Date:  2020-06-23       Impact factor: 9.910

4.  Long-Term Cognitive Impairment in Kleine-Levin Syndrome.

Authors:  Ginevra Uguccioni; Sophie Lavault; Charlotte Chaumereuil; Jean-Louis Golmard; Jean-François Gagnon; Isabelle Arnulf
Journal:  Sleep       Date:  2016-02-01       Impact factor: 5.849

5.  Kleine-Levin syndrome, GABA, and glutamate.

Authors:  Juan José Ortega-Albás; Raquel López; Alfonso Martínez; Sonia Carratalá; Ivan Echeverria; Patricia Ortega
Journal:  J Clin Sleep Med       Date:  2021-03-01       Impact factor: 4.062
  5 in total
  1 in total

1.  A case of Kleine-Levin syndrome successfully treated with Escitalopram.

Authors:  Balaswamy Reddy; Sakshi Prasad; Soumitra Das
Journal:  SAGE Open Med Case Rep       Date:  2022-07-12
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.